Full Professor
Nagoya City University, Japan
Disclosure(s): Asahi Kasei Pharma Corporation: Honoraria; AstraZeneca K.K: Honoraria; BD Co, Ltd: Honoraria; bioMérieux Japan Ltd: Honoraria; Gilead Sciences Inc: Honoraria; GlaxoSmithKline: Honoraria; Meiji Seika Pharma Co, Ltd: Honoraria; MSD K.K: Honoraria; Pfizer;: Honoraria; shimadzu co ltd: Grant/Research Support; Shionogi Co, Ltd: Honoraria
Naoya Itoh MD, DTM&H, PhD, Department of Infectious Diseases, Graduate School of Medical Sciences, Nagoya City University
Education background
2020- 2023 Collaborative Chairs Emerging and Reemerging Infectious Diseases, National Center for Global Health and Medicine, Graduate School of Medicine, Tohoku University
2019 DTM&H., Faculty of Tropical Medicine, Mahidol University
2001-2007 M.D., Tokai University of Medicine
Career background
2024- Full Professor, Graduate School of Medical Sciences, Nagoya City University
2022- Clinical Associate Professor, Shimane University School of Medicine
2020- Head Physician in Infectious Disease, Aichi Cancer Center
2018-2019 Deputy Head Physician in Infectious Disease, Shizuoka Cancer Center Hospital
2015-2018 Fellow in Infectious Disease, Shizuoka Cancer Center Hospital
1. Itoh N. Risk of Underexposure and Lack of Efficacy of Cefiderocol by Reduced Dosing in Japanese Patients With Gram-Negative Bacterial Infections. Ther Drug Monit. 2025 May 2.
2. Itoh N, et al. Impact of BD BACTEC blood culture bottle shortage on performance metrics: An interrupted time-series analysis at a Japanese university-affiliated hospital. J Infect Chemother. 2025 Apr;31(4):102664.
3. Itoh N, et al. Efficiency of a Long-term Infectious Diseases Consultation and Antimicrobial Stewardship Program at a Japanese Cancer Center: An Interrupted Time-Series Analysis. Open Forum Infect Dis. 2024 Nov 13;11(12):ofae678.
4. Itoh N, et al. Improving diagnostic accuracy of blood culture-positive cases in a cancer center via an antimicrobial stewardship program and infectious disease consultations. Sci Rep. 2024 Feb 4;14(1):2869.
5. Itoh N, et al. Reduction strategies for inpatient oral third-generation cephalosporins at a cancer center: An interrupted time-series analysis. PLoS One. 2023 Feb 9;18(2):e0281518.
Prizes and awards
2023. JIC Reviewer of the Year 2022
2019. Chamlong-Tranakchit Harinasuta Award, Mahidol University Faculty of Tropical Medicine
2024. JIC Reviewer of the Year 2023
2025. The 2024 Travel Award of the Japanese Society for Environmental Infections